Zacks Bull and Bear of the Day Highlights: Dr. Reddy's, Sony Corp., BT Group and COPEL

Zacks Equity Research highlights Dr. Reddys Laboratories (NYSE: RDY) as the Bull of the Day and Sony Corporation (NYSE: SNE) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on BT Group, Plc (NYSE: BT) and COPEL (NYSE: ELP). Full analysis of all four stocks is available at

Here is a synopsis of all four stocks:

Bull of the Day:

Our Bull of the Day recommendation is for Dr. Reddys Laboratories (NYSE: RDY). Dr. Reddy's Laboratories, Ltd. is a global pharmaceutical company located in Hyderabad, India. RDY produces active pharmaceutical ingredients (API), finished dosage forms, and branded and generic pharmaceutical products for the global market. The company has a healthy pipeline and is an active participant in terms of international product filings. During fiscal 2007, RDY experienced both top-line and bottom-line growth thanks to many products going off-patent over the past several months. RDY currently has 69 ANDAs [abbreviated new drug applications] filed with the U.S. FDA [Food & Drug Administration], which should present future growth opportunities for the company. We maintain our Buy recommendation with a target of $19.

Bear of the Day:

Our Bear of the Day recommendation is for Sony Corporation (NYSE: SNE). We believe Sony will continue to struggle as it faces competition from innovative digital products and struggles to ramp production of its PlayStation 3. In addition, Sony is facing increasing competition from low-cost manufacturers in Asia as the consumer market slows. We therefore maintain a Sell recommendation on SNE shares with a price target of $38.00.

Analyst Blog:

BT Group, Plc (NYSE: BT) reported an in-line fourth quarter on May 17th, 2007, with revenues beating our estimates and earnings slightly below our expectations. While the company has initiated several new cost-cutting measures, we would still like to see some EBITDA [earnings before interest, taxes, depreciation and amortization] margin improvements going forward. We have raised our earnings estimates for 2008 and 2009 as the company continues to improve its profitability and margins, and its recent share-buyback initiative should help boost the EPS [earnings per share] and share price. We have also upped our target price to $64.50 over the next six months, although we continue to rate shares of BT a Hold.

We are keeping our Buy recommendation on Companhia Paranaense de Energia, or COPEL (NYSE: ELP). The company's first quarter results were positive, as we expected, and the short-term outlook remains positive as well. Additionally, the outlook for energy consumption in Brazil in the medium-to-long term is very encouraging. We also believe the business environment for COPEL remains solid thanks to good hydrology and the recently released economic plan that will benefit electric utilities companies. Finally, the company's valuation remains attractive.

Get the full analysis of all four stocks by going to

About the Bull and Bear of the Day

Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.

About the Analyst Blog

Updated throughout every trading day, the Analyst Blog provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting

About Zacks is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros by going to

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

(a)The Zacks Performance Rank performance is the total return of equal weighted simulated portfolios consisting of those stocks with the indicated Zacks Rank net of fees. Results reflect the reinvestment of dividends and other earnings. Simulated results do not represent actual trading and may not reflect the impact that economic and market factors might have had on decision-making if an adviser were actually managing a client's money.

(b)The S&P 500 Index ("S&P 500") is a well-known, unmanaged index of the prices of 500 large-company common stocks selected by Standard & Poor's. The S&P 500 includes the reinvestment of all dividends, no transaction costs, and represents the gross returns before management fees.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.